Computer tool aims to personalize colon cancer screening for the uninsured
NCT ID NCT03705897
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study tests a computerized tool that collects patient information and generates personalized, guideline-based next steps for colorectal cancer screening. It focuses on a large, diverse population of under- and uninsured patients in Dallas. The goal is to improve screening rates and reduce over- or under-screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a computerized risk stratification tool that collects patient data and generates personalized screening recommendations
- What this could lead to
- If successful, this approach could help ensure that more people get the right colorectal cancer screening at the right time, potentially reducing cancer deaths.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new drug or therapy. The tool's impact on actual cancer outcomes remains to be seen.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Can a walking routine alter cancer biomarkers? new trial investigates
- Web tool aims to empower rare cancer patients in genomic choices